✦ LIBER ✦

Contemporary use of perioperative cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer

✍ Scribed by Ganesh V. Raj; Saumil Karavadia; Bruce Schlomer; Yull Arriaga; Yair Lotan; Arthur Sagalowsky; Eugene Frenkel

Book ID: 111700011
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 131 KB
Volume: 117
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.25429

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic significance of adjuvant cisp

Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer

✍ Mototsugu Muramaki; Hideaki Miyake; Toshifumi Kurahashi; Atsushi Takenaka; Taka- 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB

The role of surveillance in the treatmen

The role of surveillance in the treatment of patients with muscle-invasive bladder cancer after chemotherapy

✍ Nicholas J. Hellenthal; Michelle L. Ramirez; Christopher P. Evans; Ralph W. DeVe 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB

Carboplatin, methotrexate, and vinblasti

Carboplatin, methotrexate, and vinblastine in patients with bladder cancer who were ineligible for cisplatin-based chemotherapy

✍ J. Bellmunt; J. Albanell; O. S. Gallego; A. Ribas; P. Vicente; J. Carulla; J. De 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 622 KB

Background. A Phase I1 trial with a new regimen of methotrexate, carboplatin, and vinblastine (M-CAVI) was conducted for patients with bladder cancer who could not receive cisplatin-based chemotherapy. Methods. Treatment consisted of methotrexate (30 mg/m2) on days 1,15, and 22; carboplatin (300 mg

Contemporary management of patients with

Contemporary management of patients with high-risk non-muscle-invasive bladder cancer who fail intravesical BCG therapy

✍ D. R. Yates; M. Rouprêt 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 197 KB

Long-term follow up of patients with inv

Long-term follow up of patients with invasive bladder carcinoma receiving combined cisplatin-based intra-arterial chemotherapy and radiotherapy

✍ Ken-Ichi Mori; Koichiro Nomata; Mitsuru Noguchi; Jiro Eguchi; Nobuyuki Hayashi; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

THE STATUS OF BLADDER-PRESERVING THERAPE

THE STATUS OF BLADDER-PRESERVING THERAPEUTIC STRATEGIES IN THE MANAGEMENT OF PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER

✍ K. Koiso (c); W. Shipley (cc); F. Keuppens (cc); L. Baert; R. Hall; M'Liss A Hud 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 862 KB